P1.16-63 The Value of Adjuvant Chemotherapy in Patients with Resected Stage IB Solid Predominant and Solid Non-Predominant Lung Adenocarcinoma
2018 ◽
Vol 13
(10)
◽
pp. S654
S. Cao
◽
H. Zhong
◽
J. Xu
2018 ◽
Vol 155
(3)
◽
pp. 1227-1235.e2
◽
Fangfei Qian
◽
Wenjia Yang
◽
Rui Wang
◽
Jianlin Xu
◽
Shuyuan Wang
◽
...
2018 ◽
Vol 10
(2)
◽
pp. 249-255
Shuhui Cao
◽
Jiajun Teng
◽
Jianlin Xu
◽
Baohui Han
◽
Hua Zhong
2018 ◽
Vol 13
(4)
◽
pp. S58
S. Cao
◽
J. Xu
◽
H. Zhong
2016 ◽
Vol 101
(4)
◽
pp. 1346-1353
◽
Jung-Jyh Hung
◽
Yu-Chung Wu
◽
Teh-Ying Chou
◽
Wen-Juei Jeng
◽
Yi-Chen Yeh
◽
...
2009 ◽
Vol 5
(1)
◽
pp. 19-22
◽
Hossein Borghaei
◽
Ranee Mehra
◽
George Simon
2017 ◽
Vol 12
(11)
◽
pp. S1983
M.K. Byun
◽
H.J. Park
◽
H.S. Park
◽
H. Jeung
◽
J.Y. Cho
◽
...
2018 ◽
Vol 10
(9)
◽
pp. 5384-5393
◽
Minjie Ma
◽
Yunlang She
◽
Yijiu Ren
◽
Chenyang Dai
◽
Lei Zhang
◽
...
2017 ◽
Vol 25
(suppl_1)
◽
Xiao Li
◽
M Teng
◽
J Wang
2014 ◽
Vol 25
◽
pp. iv415
S. Wallerek
◽
J.B. Sorensen
2015 ◽
Vol 94
(22)
◽
pp. e903
◽
Jiaxi He
◽
Jianfei Shen
◽
Chenglin Yang
◽
Long Jiang
◽
Wenhua Liang
◽
...